| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/10/2003 | CN1441804A Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 09/10/2003 | CN1441803A Indoloquinazolinones |
| 09/10/2003 | CN1441801A Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 09/10/2003 | CN1441794A Lipid-rich plague inhibitors |
| 09/10/2003 | CN1441793A Tocotrienolquinone cyclisation product with anti-hypercholesterol effect |
| 09/10/2003 | CN1441788A Novel arylethene-sulfonamides compounds |
| 09/10/2003 | CN1441787A Modulators of TNF-alpha signaling |
| 09/10/2003 | CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues |
| 09/10/2003 | CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 09/10/2003 | CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 09/10/2003 | CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 09/10/2003 | CN1441774A Novel dicarboxylic acid derivatives |
| 09/10/2003 | CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists |
| 09/10/2003 | CN1441770A Modified forms of pharmacologically active agents and uses therefor |
| 09/10/2003 | CN1441675A Compositions and methods for achieving immune suppression |
| 09/10/2003 | CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors |
| 09/10/2003 | CN1441666A Macromolecular drug complexes and compositions containing same |
| 09/10/2003 | CN1440971A Vitronectin receptor antagnist, its preparation and use |
| 09/10/2003 | CN1440805A Coronary heart disease treating Chinese herbal medicine capsule |
| 09/10/2003 | CN1440801A Dizziness treating Chinese medicine |
| 09/10/2003 | CN1440800A Heart failure resisting Chinese medicine |
| 09/10/2003 | CN1440791A Freeze dried cyclovirobuxine injection powder for treating cardiac and cerebral vasular diseases |
| 09/10/2003 | CN1440781A Chinese medicine Xinxuening for treating cardiac and cerebral vascular diseases |
| 09/10/2003 | CN1440773A Prepn process of Qingkailing injection and injection powder and its quality control method |
| 09/10/2003 | CN1440764A Chinese medicine for treating angina pectoris type coronary heart disease and its prepn process |
| 09/10/2003 | CN1440758A Bioactive hill wasp powder and its prepn |
| 09/10/2003 | CN1440752A Recipe and prepn process of cyclovirobuxine dripping pills |
| 09/10/2003 | CN1440750A Delayed releasing kurarinol prepn |
| 09/10/2003 | CN1440749A Edaravone injection for treating acute cerebral thrombus and its prepn |
| 09/10/2003 | CN1120842C New thiazole benzimidazole derivative |
| 09/10/2003 | CN1120721C External applied ointment for treating piles |
| 09/10/2003 | CN1120710C Homorrholdal suppository of draconic sanguis and its producing method |
| 09/09/2003 | US6617457 Hydrogenolysis of the benzyl ester of quinapril in an alcoholic solvent, with hydrochloric acid and hydrogenation; removal of the solvent; addition of toluene to precipitate the product as a solvate |
| 09/09/2003 | US6617426 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury |
| 09/09/2003 | US6617361 Protocol for prevention of Alzheimer's disease involves stimulating implicit memory; psychotherapeutic or psychological supports; stimulating explicit memory; transfers learned behavior into the implicit memory. |
| 09/09/2003 | US6617359 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
| 09/09/2003 | US6617352 Compounds and methods for the inhibition of the expression of VCAM-1 |
| 09/09/2003 | US6617344 Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 09/09/2003 | US6617336 Treatment of urinary incontinence, venous insufficiency, migraine or gastrointestinal disorders |
| 09/09/2003 | US6617328 Sustained release ranolazine formulations |
| 09/09/2003 | US6617326 Imidazo-triazine derivatives as ligands for GABA receptors |
| 09/09/2003 | US6617325 Biphenyl derivatives, production thereof and uses as medicines |
| 09/09/2003 | US6617324 Substituted pyrazoles as p38 kinase inhibitors |
| 09/09/2003 | US6617322 Administering a piperazine or piperidine coupled through a linker to a benzhydril |
| 09/09/2003 | US6617134 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 09/09/2003 | US6617122 Contacting a compound with a polypeptide, in the presence of adenosine triphosphate (ATP) and detecting its binding or hydrolysis of ATP; use in treatment of coronary artery disease |
| 09/09/2003 | US6616943 Composition comprising Wenguanguo extracts and methods for preparing same |
| 09/09/2003 | CA2263566C Substituted 6,5-hetero-bicyclic derivatives |
| 09/09/2003 | CA2138026C Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
| 09/09/2003 | CA2036770C Inhibitors of nitric oxide biosynthesis |
| 09/04/2003 | WO2003073107A2 Neuropeptide receptor and uses thereof |
| 09/04/2003 | WO2003073062A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 09/04/2003 | WO2003072813A2 Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy |
| 09/04/2003 | WO2003072787A2 Method for detection of leptin receptor ligands |
| 09/04/2003 | WO2003072780A1 Novel proteins, dnas thereof and use of the same |
| 09/04/2003 | WO2003072734A2 Bipolar trans carotenoid salts and their uses |
| 09/04/2003 | WO2003072604A1 Transmembrane nfat inhibitory peptide |
| 09/04/2003 | WO2003072580A1 1-[ALKYL], 1-[HETEROARYL)ALKYL] AND 1-[ARYL)ALKYL]-7-(PYRIMIDIN-4-YL)-IMADAZO[1,2-a]PYRIMIDIN-5(1H)-ONE DERIVATIVES |
| 09/04/2003 | WO2003072579A1 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9- TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/04/2003 | WO2003072577A1 Thiazole derivatives as npy receptor antagonists |
| 09/04/2003 | WO2003072572A1 Beta3-adrenergic receptor agonists |
| 09/04/2003 | WO2003072570A1 Antidiabetic agents |
| 09/04/2003 | WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 09/04/2003 | WO2003072558A2 Arylsulfone derivatives |
| 09/04/2003 | WO2003072557A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 09/04/2003 | WO2003072556A1 Glutaminyl based dpiv inhibitors |
| 09/04/2003 | WO2003072550A1 Novel fused ring indazole compounds |
| 09/04/2003 | WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/04/2003 | WO2003072532A1 Ester compound and medicinal use thereof |
| 09/04/2003 | WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 09/04/2003 | WO2003072159A1 N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 09/04/2003 | WO2003072136A1 Antihypertensive compositions and uses thereof |
| 09/04/2003 | WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 09/04/2003 | WO2003072129A1 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences |
| 09/04/2003 | WO2003072114A1 Vascular therapeutics |
| 09/04/2003 | WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones |
| 09/04/2003 | WO2003072102A1 Peroxisome proliferator activated receptor modulators |
| 09/04/2003 | WO2003072101A1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases |
| 09/04/2003 | WO2003072100A1 Peroxisome proliferator activated receptor modulators |
| 09/04/2003 | WO2003072099A1 Peroxisome proliferator activated receptor modulators |
| 09/04/2003 | WO2003072087A1 Pharmaceutical dosage form and method for the production thereof |
| 09/04/2003 | WO2003072062A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/04/2003 | WO2003072035A2 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | WO2003072030A2 Methods for preventing or treating cardiac arrhythmia |
| 09/04/2003 | WO2003072029A2 Methods of extending corneal graft survival |
| 09/04/2003 | WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 09/04/2003 | WO2003072024A2 Methods of treating vascular disease |
| 09/04/2003 | WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 09/04/2003 | WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents |
| 09/04/2003 | WO2003048120A3 2-aryl pyrrologpyrimidines for a1 and a3 receptors |
| 09/04/2003 | WO2003045313A3 2-aminoquinoline compounds |
| 09/04/2003 | WO2003035646A3 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 09/04/2003 | WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 09/04/2003 | WO2003028739A3 Composition for preventing or treating hyperlipidemia or hyperglycemia comprising a polymer or its salt |
| 09/04/2003 | WO2003028730A3 Pharmaceutical combinations of pde-v inhibitors and other agents |
| 09/04/2003 | WO2003025162A3 Regulation of human prolyl 4-hydroxylase alpha subunit precursor |
| 09/04/2003 | WO2002079248A3 Mammalian alpha-helical protein-53 |
| 09/04/2003 | WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 09/04/2003 | WO2002078600A3 γεRACK PEPTIDE COMPOSITION AND METHOD FOR PROTECTION AGAINST TISSUE DAMAGE DUE TO ISCHEMIA |
| 09/04/2003 | WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |